WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership
29th May 2026 11:34
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | 1.775p on 16-06-2026 at 18:35:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1.85p |
| Sell | 1.70p |
| Last Trade: | Buy 16,088.00 at 1.815p |
| Day's Volume: | 338,201 |
| Last Close: | 1.775p |
| Open: | 1.775p |
| ISIN: | GB0034330679 |
| Day's Range | 1.775p - 1.775p |
| 52wk Range: | 0.85p - 8.00p |
| Market Capitalisation: | £34.56m |
| VWAP: | 1.812477p |
| Shares in Issue: | 1.95b |
Cellbxhealth (CLBX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 16,088 | 1.815p | Ordinary |
16:26:27 - 16-Jun-26 |
| Sell* | 26,000 | 1.7675p | Ordinary |
16:15:05 - 16-Jun-26 |
| Sell* | 10,101 | 1.7675p | Ordinary |
15:50:07 - 16-Jun-26 |
| Sell* | 6,000 | 1.7675p | Ordinary |
14:08:40 - 16-Jun-26 |
| Buy* | 30,000 | 1.83p | Ordinary |
12:12:04 - 16-Jun-26 |
| Buy* | 55 | 1.85p | Ordinary |
12:03:28 - 16-Jun-26 |
| Buy* | 9 | 1.85p | Ordinary |
12:01:19 - 16-Jun-26 |
| Buy* | 20,000 | 1.83p | Ordinary |
11:34:59 - 16-Jun-26 |
| Buy* | 135,000 | 1.83p | Ordinary |
10:53:14 - 16-Jun-26 |
| Buy* | 46,448 | 1.83p | Ordinary |
08:47:08 - 16-Jun-26 |
Cellbxhealth (CLBX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jun 2026 7:00 am | RNS | Notice of Results |
| 29th May 2026 7:00 am | RNS | MSA with Global Pharmaceutical Company |
| 18th May 2026 7:00 am | RNS | Collaboration with AdventHealth for two studies |
| 11th May 2026 7:00 am | RNS | Q1 trading update and outlook for 2026 |
| 30th Apr 2026 7:00 am | RNS | Confirmation of Q1 trading update |
| 20th Apr 2026 7:00 am | RNS | Research Collaboration with The Royal Marsden |
| 16th Apr 2026 5:39 pm | RNS | Board changes - Replacement |
| 13th Feb 2026 7:00 am | RNS | Aligning Regulatory Approach with Commercial Needs |
| 16th Jan 2026 7:00 am | RNS | Preliminary Fourth Quarter 2025 Financial Results |
| 12th Jan 2026 7:00 am | RNS | Board changes |